The National Center for Complementary and Alternative Medicine (NCCAM), a component of the National Institutes of Health, welcomes four new members to the National Advisory Council for Complementary and Alternative Medicine. The council serves as the principal advisory body to NCCAM, the lead federal agency for research on complementary and integrative health.
The highly distinguished NCCAM council—composed of physicians, scientists, complementary health practitioners, and members of the public—represents a broad range of science and practice. Members serve a four year term and meet three times per year to provide second level peer review, as well as other advice and recommendations on the prioritization of complementary and integrative health research.
New council members include:
Donald Craig Brater, M.D., is Emeritus Dean and Walter J. Daly Professor Emeritus of the Indiana University School of Medicine and Vice President Emeritus for University Clinical Affairs at Indiana University in Indianapolis. Dr. Brater created the Division of Clinical Pharmacology in the Department of Medicine in 1986. He has been president of the American Society for Clinical Pharmacology and Therapeutics, the Association of Professors of Medicine, the Central Society for Clinical Research, the United States Pharmacopoeia, and the Alliance for Academic Internal Medicine. He now serves as VP for Programs of the Walther Cancer Foundation and of the Regenstrief Foundation. He has published more than 130 research articles and 50 books or book chapters.
Janice K. Kiecolt-Glaser, Ph.D., holds the S. Robert Davis Chair of Medicine at The Ohio State University College of Medicine, Columbus, and the title of Distinguished University Professor. She is a member of the Ohio State University Institute for Behavioral Medicine Research as well as professor of psychiatry and psychology. Her studies in psychoneuroimmunology have demonstrated important health consequences of stress, including slower wound healing, impaired vaccine responses, and substantially accelerated age-related changes in inflammation. She was elected to the Institute of Medicine of the National Academy of Sciences. Her research has been supported by a series of grants from the National Institutes of Health, including a MERIT award.
Steven M. Hersch, M.D., Ph.D., is a professor of neurology at Massachusetts General Hospital, Charlestown. He is a neuroscientist and clinician with expertise in quantitative neuroanatomy, molecular pharmacology, experimental neuropathology of neurodegenerative diseases, discovery and validation of neuroprotective therapies and biomarkers, and clinical research and clinical trials for Huntington’s disease (HD). He is experienced in using immunologic methods to localize receptors and disease related proteins in brain, in quantitative morphology, and in using electron microscopy to analyze neuronal structure, cytology, and synapses. Dr. Hersch directs the MGH HD Center of Excellence, is co-chair of the Huntington’s Study Group, and served on the national board of trustees for the Huntington’s Disease Society of America.
Eric B. Schoomaker, M.D., Ph.D., F.A.C.P. is a scholar-in-residence and Distinguished Professor of Military and Emergency Medicine at the Uniformed Services University of the Health Sciences (USU) in Bethesda, Maryland. After four years as the U.S. Army’s top doctor, Lieutenant General Schoomaker retired in 2012 from his role as the U.S. Army Surgeon General and Commanding General of the U.S. Army Medical Command. His retirement follows 32 years of active service in uniform and 41 years as a commissioned Army officer. His principal interests at USU are in complementary and integrative health and medicine as well as leadership development and education. He is the recipient of many military awards, including those from France and Germany, the Dr. Nathan Davis Award from the American Medical Association for outstanding government service and an Honorary Doctor of Science from Wake Forest University, Winston-Salem, North Carolina.